» Authors » Jonathan N Townend

Jonathan N Townend

Explore the profile of Jonathan N Townend including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 121
Citations 1733
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Law J, Pickup L, Pavlovic D, Townend J, Ferro C
J Hum Hypertens . 2022 Sep; 37(1):1-19. PMID: 36138105
Chronic kidney disease (CKD) is a complex condition with a prevalence of 10-15% worldwide. An inverse-graded relationship exists between cardiovascular events and mortality with kidney function which is independent of...
12.
Pickup L, Law J, Townend J, Ferro C
Br J Cardiol . 2022 Jun; 27(3):25. PMID: 35747771
No abstract available.
13.
Anderson B, Qasim M, Evison F, Gallier S, Townend J, Ferro C, et al.
Kidney Int . 2022 Jun; 102(4):876-884. PMID: 35716956
Major adverse cardiovascular event (MACE) rates immediately after kidney transplantation remain uncertain due to heterogeneous reporting in the literature. To clarify this, we retrospectively studied every eligible kidney transplant procedure...
14.
Umar H, Sharma H, Osheiba M, Roy A, Ludman P, Townend J, et al.
Open Heart . 2022 Apr; 9(1). PMID: 35483748
Introduction: Coronary artery perforation (CP) is a rare but life-threatening complication of percutaneous coronary intervention (PCI). This study aimed to assess the incidence, management and outcomes of CP over time....
15.
Ferro C, Townend J
Clin Kidney J . 2022 Apr; 15(4):644-656. PMID: 35371443
The first successful live donor kidney transplant was performed in 1954. Receiving a kidney transplant from a live kidney donor remains the best option for increasing both life expectancy and...
16.
Sharma H, Yuan M, Shakeel I, Hodson J, Radhakrishnan A, Brown S, et al.
J Clin Med . 2022 Feb; 11(4). PMID: 35207254
Background: Mitral regurgitation (MR) is common following myocardial infarction (MI). However, the subsequent trajectory of MR, and its impact on long-term outcomes are not well understood. This study aimed to...
17.
Ferro C, Berry M, Moody W, George S, Sharif A, Townend J
Clin Kidney J . 2021 Dec; 14(12):2472-2482. PMID: 34950460
Screening for occult coronary artery disease in potential kidney transplant recipients has become entrenched in current medical practice as the standard of care and is supported by national and international...
18.
Sharma H, Radhakrishnan A, Nightingale P, Brown S, May J, OConnor K, et al.
Data Brief . 2021 Oct; 39:107451. PMID: 34703851
Data were collected on patients admitted to the Queen Elizabeth Hospital Birmingham with type-1 myocardial infarction during 2016 and 2017 inclusively, who were treated by percutaneous intervention and had pre-discharge...
19.
Edwards N, Price A, Mehta S, Hiemstra T, Kaur A, Greasley P, et al.
Clin J Am Soc Nephrol . 2021 Aug; 16(10):1491-1501. PMID: 34462286
Background And Objectives: In a randomized double-blind, placebo-controlled trial, treatment with spironolactone in early-stage CKD reduced left ventricular mass and arterial stiffness compared with placebo. It is not known if...
20.
Sharma H, Radhakrishnan A, Nightingale P, Brown S, May J, OConnor K, et al.
Am J Cardiol . 2021 Aug; 157:22-32. PMID: 34417016
Mitral regurgitation (MR) following acute myocardial infarction (AMI) worsens prognosis and reports of prevalence vary significantly. The objective was to determine prevalence, risk factors, and outcomes related to MR following...